SEARCH

SEARCH BY CITATION

References

  • 1
    Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer 2008; 8: 16779.
  • 2
    Phatak P,Burger AM. Telomerase and its potential for therapeutic intervention. Br J Pharmacol 2007; 152: 100311.
  • 3
    Hamad NM,Banik SS,Counter CM. Mutational analysis defines a minimum level of telomerase activity required for tumourigenic growth of human cells. Oncogene 2002; 21: 71215.
  • 4
    Shay JW,Keith WN. Targeting telomerase for cancer therapeutics. Br J Cancer 2008; 98: 67783.
  • 5
    Kim NW,Hruszkewycz AM. Telomerase activity modulation in the prevention of prostate cancer. Urology 2001; 57: 14853.
  • 6
    Cosme-Blanco W,Chang S. Dual roles of telomere dysfunction in initiation and suppression of tumorigenesis. Exp Cell Res 2008; 314: 19739.
  • 7
    Edington KG,Loughran OP,Berry IJ,Parkinson EK. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinog 1995; 13: 25465.
  • 8
    De Clercq E. Antiviral drugs in current clinical use. J Clinical Virol 2004; 30: 11533.
  • 9
    Hazen R,Harvey R,Ferris R,Craig C,Yates P,Griffin P,Miller J,Kaldor I,Ray J,Samano V,Furfine E,Spaltenstein A. In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV. Antimicrob Agents Chemother 2007; 51: 314754.
  • 10
    Yuen GJ,Weller S,Pakes GE. A review of the pharmacokinetics of Abacavir. Clin Pharmacokinet 2008; 47: 35171.
  • 11
    Wang LH,Chittick GE,McDowell JA. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection. Antimicrob Agents Chemother 1999; 43: 170815.
  • 12
    Faletto MB,Miller WH,Garvey EP,St Clair MH,Daluge SM,Good SS. Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89. Antimicrob Agents Chemother 1997; 41: 1099107.
  • 13
    Tendian SW,Parker WB. Interaction of deoxyguanosine nucleotide analogs with human telomerase. Mol Pharmacol 2000; 57: 6959.
  • 14
    Yegorov YE,Chernov DN,Akimov SS,Bolsheva NL,Krayevsky AA,Zelenin AV. Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts. FEBS Lett 1996; 389: 11518.
  • 15
    Didiano D,Shalaby T,Lang D,Grotzer MA. Telomere maintenance in childhood primitive neuroectodermal brain tumors. Neuro Oncol 2004; 6: 18.
  • 16
    Chang Q,Pang JC,Li J,Hu L,Kong X,Ng H. Molecular analysis of PinX1 in medulloblastomas. Int J Cancer 2004; 109: 30914.
  • 17
    Rossi A,Caracciolo V,Russo G,Reiss K,Giordano A. Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res 2008; 14: 9716.
  • 18
    Ferretti E,De Smaele E,Po A,Di Marcotullio L,Tosi E,Espinola MS,Di Rocco C,Riccardi R,Giangaspero F,Farcomeni A,Nofroni I,Laneve P, et al. MicroRNA profiling in human medulloblastoma. Int J Cancer 2009; 124: 56877.
  • 19
    Yoon JW,Gilbertson R,Iannaccone S,Iannaccone P,Walterhouse D. Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes. Int J Cancer 2009; 124: 10919.
  • 20
    He X,Ostrowski LE,von Wronski MA,Friedman HS,Wikstrand CJ,Bigner SH,Rasheed A,Batra SK,Mitra S,Brent TP,Bigner DD. Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines. Cancer Res 1992; 52: 11448.
  • 21
    Friedman HS,Burger PC,Bigner SH,Trojanowski JQ,Wikstrand CJ,Halperin EC,Bigner DD. Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med. J Neuropathol Exp Neurol 1985; 44: 592605.
  • 22
    Kim N,Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997; 25: 25957.
  • 23
    Dalla Torre CA,Maciel RM,Pinheiro NA,Andrade JA,De Toledo SR,Villa LL,Cerutti JM. TRAP-silver staining, a highly sensitive assay for measuring telomerase activity in tumor tissue and cell lines. Braz J Med Biol Res 2002; 35: 658.
  • 24
    Landriscina M,Fabiano A,Altamura S,Bagalà C,Piscazzi A,Cassano A,Spadafora C,Giorgino F,Barone C,Cignarelli M. Reverse transcription inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake un human thyroid anaplastic carcinoma. J Clin Endocrinol Metab 2005; 90: 566371.
  • 25
    Gao K,Lu YR,Wei LL,Lu XF,Li SF,Wan L,Li YP,Cheng JQ. Immortalization of mesenchymal stem cells from bone marrow of rhesus monkey by transfection with human telomerase reverse transcriptase gene. Transplant Proc 2008; 40: 6347.
  • 26
    Chavez SJ,Meneses JJ,Nguyen HN,Kim SK,Pera RA. Characterization of six new human embryonic stem cell lines (HSF7, -8, -9, -10, -12, and -13) derived under minimal-animal component conditions. Stem Cells Dev 2008; 17: 53546.
  • 27
    Deng Y,Chan SS,Chang S. Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer 2008; 8: 4508.
  • 28
    Minty F,Thurlow JK,Harrison PR,Parkinson EK. Telomere dysfunction in human keratinocytes elicits senescence and a novel transcription profile. Exp Cell Res 2008; 314: 243447.
  • 29
    He XM,Wikstrand CJ,Friedman HS,Bigner SH,Pleasure S,Trojanowski JQ,Bigner DD. Differentiation characteristics of newly established medulloblastoma cell lines (D384Med. D425 Med and. D458 Med) and their transplantable xenografts. Lab Investig 1994; 64: 83343.
  • 30
    Soylemezoglu F,Soffer D,Onol B,Schwechheimer K,Kleihues P. Lipomatous medulloblastoma in adults. A distinct clinicopathological entity. Am J Surg Pathol 1996; 20: 41318.
  • 31
    Cai DX,Mafra M,Schmidt RE,Scheithauer BW,Park TS,Perry A. Medulloblastomas with extensive posttherapy neuronal maturation. Report of two cases. J Neurosurg 2000; 93: 3304.
  • 32
    Shay JW,Wright WE. Senescence and immortalization: role of telomeres and telomerease. Carcinogenesis 2005; 26: 86774.
  • 33
    Daluge SM,Good SS,Faletto MB,Miller WH,St Clair MH,Boone LR,Tisdale M,Parry NR,Reardon JE,Dornsife RE,Averett DR,Krenitsky TA. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Antimicrob Agents Chemother 1997; 41: 108293.
  • 34
    Shammas MA,Koley H,Bertheau RC,Neri P,Fulciniti M,Tassone P,Blotta S,Protopopov A,Mitsiades C,Batchu RB,Anderson KC,Chin A, et al. Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo. Leukemia 2008; 22: 141018.
  • 35
    De Clercq E. AIDS in the Third World: how to stop the HIV infection? Verh K Acad Geneeskd Belg 2007; 69: 6580.
  • 36
    Cassar L,Li H,Pinto AR,Nicholls C,Bayne S,Liu JP. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. Cancer Res 2008; 68: 915766.
  • 37
    Zhu X,Kumar R,Mandal M,Sharma N,Sharma HW,Dhingra U,Sokolski JA,Hsiao R,Narayanan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci U S A 1996; 93: 60915.
  • 38
    Ye Y,Yang HY,Wu J,Li M,Min JM,Cui JR. Z-ajoene causes cell cycle arrest at G2/M and decrease of telomerase activity in HL60 cells. Zhonghua Zhong Liu Za Zhi 2005; 27: 51620.
  • 39
    Oliva JL,Caino MC,Senderowicz AM,Kazanietz MG. S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells. J Biol Chem 2008; 283: 546676.
  • 40
    Tomàs-Loba A,Flores I,Fernandez-Marcos PJ,Cayuela ML,Maraver A,Tejera A,Borràs C,Matheu A,Klatt P,Flores JM,Vina J,Serrano M, et al. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 2008; 135: 60922.
  • 41
    de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19: 210010.
  • 42
    Goldkorn A,Blackburn EH. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells. Cancer Res 2006; 66: 576371.
  • 43
    Damm K,Hemmann U,Garin-Chesa P,Hauel N,Kauffmann I,Priepke H,Niestroj C,Daiber C,Enenkel B,Guilliard B,Lauritsch I,Muller E. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J 2001; 20: 695868.
  • 44
    Guo JM,Xiao BX,Liu Q,Zhang S,Liu DH,Gong ZH. Anticancer effect of aloe-emodin on cervical cancer cells involves G2/M arrest and induction of differentiation. Acta Pharmacol Sin 2007; 28: 19915.
  • 45
    Chang Q,Chen Z,You J,McNutt MA,Zhang T,Han Z,Zhang X,Gong E,Gu J. All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line. J Neurooncol 2007; 84: 2637.
  • 46
    Sadatomo T,Yoshida J,Wakabayashi T,Mizuno M,Harada K,Kurisu K,Uozumi T,Sugita K. New approach for the treatment of medulloblastoma by transfection with glial fibrillary acidic protein gene. Surg Oncol 1996; 5: 6975.
  • 47
    Witzig TE,Timm M,Stenson M,Svingen PA,Kaufmann SH. Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents. Clin Cancer Res 2000; 6: 68192.
  • 48
    Sanz MA,Martin G,Diaz-Mediavilla J. All-trans-retinoic acid in acute promyelocytic leucemia. N Engl J Med 1998; 338: 3934.
  • 49
    Arabinda D,Naren LB,Swapan KR. Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG. J Neuooncol 2008; 87: 922.
  • 50
    Anthonypillai C,Sanderson RN,Gibbs JE,Thomas SA. The distribution of the HIV protease inhibitor, ritonavir, to the brain, cerebrospinal fluid, and choroid plexuses of the guinea pig. J Pharmacol Exp Ther 2004; 308: 91220.
  • 51
    Matsutani M. Chemotherapy for brain tumors: current status and perspectives. Int J Clin Oncol 2004; 9: 4714.